A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42% Oct 22, 2026 · Alice Park · time.com read more » The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer. Read more »